KM survival analysis also revealed that CHD5 expression was associated with reduced PFI in PRAD (Figure A3B, p < 0.01), COAD (Figure A3C, p < 0.001) and COADREAD (Figure A3D, p < 0.001) patients. The gene discussed is CHD5; the disease is prostate adenocarcinoma.